231 related articles for article (PubMed ID: 22876054)
1. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
Ryu YJ; Yoon JH
Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
[TBL] [Abstract][Full Text] [Related]
4. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.
Zhang Y; Ma XP; Deng FS; Liu ZR; Wei HQ; Wang XH; Chen H
World J Surg Oncol; 2014 Sep; 12():277. PubMed ID: 25179111
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.
Yoon YH; Kim HJ; Lee JW; Kim JM; Koo BS
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1013-7. PubMed ID: 21822854
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
Kim WW; Ha TK; Bae SK
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
[TBL] [Abstract][Full Text] [Related]
10. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma.
Jara SM; Carson KA; Pai SI; Agrawal N; Richmon JD; Prescott JD; Dackiw A; Zeiger MA; Bishop JA; Tufano RP
Surgery; 2013 Dec; 154(6):1272-80; discussion 1280-2. PubMed ID: 24238047
[TBL] [Abstract][Full Text] [Related]
11. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
[TBL] [Abstract][Full Text] [Related]
13. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients.
Ma B; Chen X; Zhao Z; Yin X; Ji Q; Zhou Y; Ma C; Wang J
BMC Endocr Disord; 2022 Mar; 22(1):55. PubMed ID: 35255870
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
15. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
Nam HY; Lee HY; Park GC
Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
[TBL] [Abstract][Full Text] [Related]
16. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
Lee I; Kim HK; Soh EY; Lee J
World J Surg; 2020 May; 44(5):1506-1513. PubMed ID: 31915977
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
18. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
[TBL] [Abstract][Full Text] [Related]
19. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma.
Kim HG; Kim EK; Han KH; Kim H; Kwak JY
Yonsei Med J; 2014 Jul; 55(4):879-85. PubMed ID: 24954314
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
